Abstract
We performed a systematic review and meta-analysis of randomized controlled trials (RCTs) to assess the effects of magnesium (Mg) supplementation on the lipid profile in type 2 diabetes (T2DM) patients. Web of Science, Scopus, PubMed, and Embase databases were searched to infinity until 30 January 2020. Weighted mean differences (WMD) were pooled using a random-effects model. Heterogeneity, sensitivity analysis, and publication bias were reported using standard methods. The pooled analysis of 12 randomized controlled trials indicated that Mg administration led to significant reduction of serum low-density lipoprotein (LDL) levels (p = 0.006). However, our results revealed that Mg supplementation did not have any effect on triglycerides (TG), total cholesterol (TC), and high-density lipoprotein (HDL) serum concentrations among T2DM patients in comparison with the control group. Subgroup analysis based on duration of study suggested that more than 12 weeks of Mg supplementation significantly decreased the serum TC levels (p = 0.002). Subgroup analysis comparing the dose of intervention indicated that Mg supplementation less than 300 mg significantly decreased the serum LDL concentrations (p < 0.001), while more than 300 mg of Mg supplementation significantly increased the serum HDL levels (p = 0.026). In a subgroup analysis comparing the type of intervention, it displayed that inorganic Mg supplementation decreased the LDL (p < 0.001) and TC (p = 0.003) levels, while organic Mg supplementation showed no difference. Mg supplementation has a beneficial effect on lowering LDL level in T2DM patients. However, we have to note that any research performed so far is not sufficient for making robust guidelines to use Mg supplementation in clinical practice.
Similar content being viewed by others
References
Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87(1):4–14
Beigrezaei S, Ghiasvand R, Feizi A, Iraj B (2019) Relationship between dietary patterns and incidence of type 2 diabetes. Int J Prev Med 10(122): 2
Shi Y, Hu FB (2014) The global implications of diabetes and cancer. Lancet (London, England) 383(9933):1947
Namazi N, Tarighat A, Bahrami A (2012) The effect of hydro alcoholic nettle (Urtica dioica) extract on oxidative stress in patients with type 2 diabetes: a randomized double-blind clinical trial. Pak J Biol Sci 15(2):98–102
Hosseini SM, Amini M, Roosta S, Beigrezaei S (2016) Trends of serum creatinine among patients with type 2 diabetes in Isfahan endocrine and metabolism research center; a longitudinal study. J Prev Epidemiol 2(1): e01
Motedayen M, Sarokhani D, Meysami A, Jouybari L, Sanagoo A, Hasanpour DA (2018) The prevalence of hypertension in diabetic patients in Iran; a systematic review and meta-analysis. J Nephropathol 7(3):137–144
Zhou Y, Wang C, Shi K, Yin X (2018) Relationship between dyslipidemia and diabetic retinopathy: a systematic review and meta-analysis. Medicine 97(36):e12283
Mohammadi H, Hadi A, Arab A, Moradi S, Rouhani MH (2019) Effects of silymarin supplementation on blood lipids: a systematic review and meta-analysis of clinical trials. Phytother Res 33(4):871–880
Ghaedi E, Moradi S, Aslani Z, Kord-Varkaneh H, Miraghajani M, Mohammadi H (2019) Effects of grape products on blood lipids: a systematic review and dose–response meta-analysis of randomized controlled trials. Food Funct 10(10):6399–6416
Behradmanesh S, Nasri P (2012) Serum cholesterol and LDL-C in association with level of diastolic blood pressure in type 2 diabetic patients. J Renal Inj Prev 1(1):23–26
Nasri H, Shirzad H, Baradaran A, Rafieian-Kopaei M (2015) Antioxidant plants and diabetes mellitus. J Res Med Sci 20(5):491
Jonnalagadda VG, Shravan Kumar U, Afsar S (2018) Effect of metformin or Chinese herbal formula in patients with type 2 diabetes mellitus and hyperlipidemia: a reassessment. mBio 24;9(4):e01173–18
Barbagallo M, Dominguez LJ (2015) Magnesium and type 2 diabetes. World J Diabetes 6(10):1152–1157
Niknazar F, Aberumand M, Rostami R, Seyed TM (2013) Evaluation of serum magnesium in type II diabetic patients. Med Lab J 7(1):12–16
Barbagallo M, Dominguez LJ, Galioto A, Ferlisi A, Cani C, Malfa L, Pineo A, Busardo’ A, Paolisso G (2003) Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Asp Med 24(1–3):39–52
Corica F, Allegra A, Di AB, Giacobbe M, Romano G, Cucinotta D et al (1994) Effects of oral magnesium supplementation on plasma lipid concentrations in patients with non-insulin-dependent diabetes mellitus. Magnes Res 7(1):43–47
Rashvand S, Mobasseri M, Tarighat-Esfanjani A (2019) Effects of choline and magnesium concurrent supplementation on coagulation and lipid profile in patients with type 2 diabetes mellitus: a pilot clinical trial. Biol Trace Elem Res194(2):328–335
Wang J (1987) Determination of intraerythrocytic Na+, K+, Ca++, Mg++ and cell-membrane Na+-K+-ATPase activities: its diagnostic value in digoxin poisoning. Zhonghua Yi Xue Za Zhi 67(7):366
McNair P, Christiansen C, Madsbad S, Lauritzen E, Faber O, Binder C, Transbol I (1978) Hypomagnesemia, a risk factor in diabetic retinopathy. Diabetes. 27(11):1075–1077
McNair P, Christensen MS, Christiansen C, Madsbad S, Transbøl I (1982) Renal hypomagnesaemia in human diabetes mellitus: its relation to glucose homeostasis. Eur J Clin Investig 12(1):81–85
Paolisso G, Ravussin E (1995) Intracellular magnesium and insulin resistance: results in Pima Indians and Caucasians. J Clin Endocrinol Metab 80(4):1382–1385
Nasri H (2014) Consequences of hypomagnesemia in type 2 diabetes mellitus patients. J Renal Inj Prev 3(4):99–100
Madihi Y, Marikhi A, Nasri H (2013) Prevention of hypomagnesemia in diabetes patients. Int J Prev Med 1(1):982–983
Nasri H, Baradaran H-R (2008) Lipids in association with serum magnesium in diabetes mellitus patients. Bratisl Lek Listy 109(7):302–306
Solati M, Ouspid E, Hosseini S, Soltani N, Keshavarz M, Dehghani M (2014) Oral magnesium supplementation in type II diabetic patients. Med J Islam Repub Iran 28:67
Sadeghian M, Azadbakht L, Khalili N, Mortazavi M, Esmaillzadeh A (2020) Oral magnesium supplementation improved lipid profile but increased insulin resistance in patients with diabetic nephropathy: a double-blind randomized controlled clinical trial. Biol Trace Elem Res 193(1):23–35
De Valk H, Verkaaik R, Van Rijn H, Geerdink R, Struyvenberg A (1998) Oral magnesium supplementation in insulin-requiring type 2 diabetic patients. Diabet Med 15(6):503–507
Mansouri A, Norouzi S, Sharifi A, YektaKooshali MH, Azami M (2017) The relationship of maternal subclinical hypothyroidism during pregnancy and preterm birth: a systematic review and meta-analysis of cohort studies. J Clin Endocrinol Metab 19(40):69–78
Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097
Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD et al (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. Bmj. 343:d5928
Mirenayat MS, Moradi S, Mohammadi H, Rouhani MH (2018) Effect of L-citrulline supplementation on blood pressure: a systematic review and meta-analysis of clinical trials. Curr Hypertens Rep 20(11):98
Moradi S, Ziaei R, Foshati S, Mohammadi H, Nachvak SM, Rouhani MH. Effects of Spirulina supplementation on obesity: A systematic review and metaanalysis of randomized clinical trials. Complementary therapies in medicine. 2019;47:102211
DerSimonian R, Kacker R (2007) Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials 28(2):105–114
Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 14(1):135
Eibl NL, Kopp H-P, Nowak HR, Schnack CJ, Hopmeier PG, Schernthaner G (1995) Hypomagnesemia in type II diabetes: effect of a 3-month replacement therapy. Diabetes Care 18(2):188–192
RodrÃguez-Morán M, Guerrero-Romero F (2003) Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care 26(4):1147–1152
Barragán-RodrÃguez L, RodrÃguez-Morán M, Guerrero-Romero F (2008) Efficacy and safety of oral magnesium supplementation in the treatment of depression in the elderly with type 2 diabetes: a randomized, equivalent trial. Magnes Res 21(4):218–223
Guerrero-Romero F, Rodriguez-Moran M (2009) The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo-controlled clinical trial. J Hum Hypertens 23(4):245–251
Navarrete-Cortes A, Ble-Castillo JL, Guerrero-Romero F, Cordova-Uscanga R, Juárez-Rojop IE, Aguilar-Mariscal H, et al. No effect of magnesium supplementation on metabolic control and insulin sensitivity in type 2 diabetic patients with normomagnesemia. Magnesium research. 2014;27(2):48–56
Razzaghi R, Pidar F, Momen-Heravi M, Bahmani F, Akbari H, Asemi Z (2018) Magnesium supplementation and the effects on wound healing and metabolic status in patients with diabetic foot ulcer: a randomized, double-blind, placebo-controlled trial. Biol Trace Elem Res 181(2):207–215
Sadeghian M, Azadbakht L, Khalili N, Mortazavi M, Esmaillzadeh A (2019) Oral magnesium supplementation improved lipid profile but increased insulin resistance in patients with diabetic nephropathy: a double-blind randomized controlled clinical trial. Biol Trace Elem Res 193(1):23–35
Talari HR, Zakizade M, Soleimani A, Bahmani F, Ghaderi A, Mirhosseini N, Eslahi M, Babadi M, Mansournia MA, Asemi Z (2019) Effects of magnesium supplementation on carotid intima-media thickness and metabolic profiles in diabetic haemodialysis patients: a randomised, double-blind, placebo-controlled trial. Br J Nutr 121(7):809–817
Nasri H, Behradmanesh S, Ahmadi A, Baradaran A, Nasri P, Rafieian-Kopaei M (2014) Association of serum lipids with level of blood pressure in type 2 diabetic patients. J Renal Inj Prev 3(2):43
Gatmiri SM, Khadem E, Fakhrian T, Kamalinejad M, Hosseini H, Ghorat F, Alamdari A, Naderi N (2019) The effect of artichoke leaf extract supplementation on lipid profile of chronic kidney disease patients; a double-blind, randomized clinical trial. J Renal Inj Prev 8(3):225–229
Rashvand S, Mobasseri M, Tarighat-Esfanjani A (2019) Effects of choline and magnesium concurrent supplementation on coagulation and lipid profile in patients with type 2 diabetes mellitus: a pilot clinical trial. Biol Trace Elem Res 194(2):328–335
Pourjam R, Estebsari F, ZRK K, Estebsri K, Mostafaei D (2019) An analytical study of the factors affecting the health promoting lifestyle; comparison of type II diabetic patients with healthy people. J Renal Inj Prev 8(3): 247–252
Kaveh P, Tehrani AM, Mardani S (2020) Association of serum magnesium level with resistant hyperlipidemia in diabetic and hypertensive patients. J Nephropharmacol 9(1): e07
Verma H, Garg R (2017) Effect of magnesium supplementation on type 2 diabetes associated cardiovascular risk factors: a systematic review and meta analysis.J Hum Nutr Diet 30(5):621–633
Simental-MendÃa LE, Simental-MendÃa M, Sahebkar A, RodrÃguez-Morán M, Guerrero-Romero F (2017) Effect of magnesium supplementation on lipid profile: a systematic review and meta-analysis of randomized controlled trials. Eur J Clin Pharmacol 73(5):525–536
Coudray C, Rambeau M, Feillet-Coudray C, Gueux E, Tressol J, Mazur A, Rayssiguier Y (2005) Study of magnesium bioavailability from ten organic and inorganic Mg salts in Mg-depleted rats using a stable isotope approach. Magnes Res 18(4):215–223
Guerrero-Romero F, Jaquez-Chairez FO, Rodriguez-Moran M (2016) Magnesium in metabolic syndrome: a review based on randomized, double-blind clinical trials. Magnes Res 29(4):146–153
Marques B, Klein M, da Cunha MR, de Souza Mattos S, de Paula Nogueira L, de Paula T, et al. Effects of Oral magnesium supplementation on vascular function: a systematic review and meta-analysis of randomized controlled trials. High Blood Press Cardiovasc Prev 27(1):19–28
Navarro-González JF, Mora-Fernández C, GarcÃa-Pérez J (eds) (2009) Reviews: clinical implications of disordered magnesium homeostasis in chronic renal failure and dialysis. Seminars in dialysis. Semin Dial 22(1):37–44
Noale M, Limongi F, Maggi S (2020) Epidemiology of cardiovascular diseases in the elderly. Adv Exp Med Biol 1216:29–38
Taghizadeh E, Esfehani RJ, Sahebkar A. Familial combined hyperlipidemia: an overview of the underlying molecular mechanisms and therapeutic strategies IUBMB Life 71(9):1221–1229
van Reedt Dortland AK, Vreeburg SA, Giltay EJ, Licht CM, Vogelzangs N, van Veen T et al (2013) The impact of stress systems and lifestyle on dyslipidemia and obesity in anxiety and depression. Psychoneuroendocrinology. 38(2):209–218
Schoeler M, Caesar R. Dietary lipids, gut microbiota and lipid metabolism Rev Endocr Metab Disord 20(4):461–472
Rosanoff A, Seelig MS (2004) Comparison of mechanism and functional effects of magnesium and statin pharmaceuticals. J Am Coll Nutr 23(5):501S–505S
Simental-Mendia LE, Simental-Mendia M, Sahebkar A, Rodriguez-Moran M, Guerrero-Romero F (2017) Effect of magnesium supplementation on lipid profile: a systematic review and meta-analysis of randomized controlled trials. Eur J Clin Pharmacol 73(5):525–536
Kanbay M, Goldsmith D, Uyar ME, Turgut F, Covic A (2010) Magnesium in chronic kidney disease: challenges and opportunities. Blood Purif 29(3):280–292
Spiegel DM (2011) Magnesium in chronic kidney disease: unanswered questions. Blood Purif 31(1–3):172–176
Sultan S, Jahangir A, Gussak IB, Kostis JB, JamilTajik A, Jahangir A (2018) CHAPTER 29. Interactions between supplements and medications. Iatrogenicity: causes and consequences of iatrogenesis in cardiovascular medicine:370–389
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Asbaghi, O., Moradi, S., Nezamoleslami, S. et al. The Effects of Magnesium Supplementation on Lipid Profile Among Type 2 Diabetes Patients: a Systematic Review and Meta-analysis of Randomized Controlled Trials. Biol Trace Elem Res 199, 861–873 (2021). https://doi.org/10.1007/s12011-020-02209-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-020-02209-5